FR2531088B1 - Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation - Google Patents

Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation

Info

Publication number
FR2531088B1
FR2531088B1 FR8213250A FR8213250A FR2531088B1 FR 2531088 B1 FR2531088 B1 FR 2531088B1 FR 8213250 A FR8213250 A FR 8213250A FR 8213250 A FR8213250 A FR 8213250A FR 2531088 B1 FR2531088 B1 FR 2531088B1
Authority
FR
France
Prior art keywords
preparation
products derived
methylenediphosphonic acid
inflammatory products
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8213250A
Other languages
English (en)
French (fr)
Other versions
FR2531088A1 (fr
Inventor
Jean-Claude Breliere
Xavier Emonds-Alt
George Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR8213250A priority Critical patent/FR2531088B1/fr
Priority to IE1716/83A priority patent/IE56343B1/en
Priority to DK336783A priority patent/DK170342B1/da
Priority to DE8383401520T priority patent/DE3374062D1/de
Priority to LU88723C priority patent/LU88723I2/fr
Priority to NO832701A priority patent/NO164712C/no
Priority to AT83401520T priority patent/ATE30235T1/de
Priority to EP83401520A priority patent/EP0100718B1/fr
Priority to IL69347A priority patent/IL69347A/xx
Priority to CA000433224A priority patent/CA1267650A/en
Priority to PH29310A priority patent/PH22082A/en
Priority to AU17324/83A priority patent/AU566880B2/en
Priority to GR72051A priority patent/GR79597B/el
Priority to PT77122A priority patent/PT77122B/pt
Priority to ES524495A priority patent/ES524495A0/es
Priority to HU832658A priority patent/HU190454B/hu
Priority to NZ205061A priority patent/NZ205061A/en
Priority to OA58074A priority patent/OA07507A/xx
Priority to MA20079A priority patent/MA19858A1/fr
Priority to KR1019830003523A priority patent/KR910000726B1/ko
Priority to PL1983259142A priority patent/PL142022B1/pl
Priority to SU833628775A priority patent/SU1333240A3/ru
Priority to FI832758A priority patent/FI75830C/fi
Priority to CS835688A priority patent/CS252463B2/cs
Priority to PL1983243229A priority patent/PL141316B1/pl
Priority to YU1600/83A priority patent/YU45143B/xx
Priority to DD83253536A priority patent/DD213670A5/de
Priority to JP58139324A priority patent/JPS5942395A/ja
Priority to ZA835578A priority patent/ZA835578B/xx
Priority to EG468/83A priority patent/EG15968A/xx
Priority to DZ836911A priority patent/DZ562A1/fr
Publication of FR2531088A1 publication Critical patent/FR2531088A1/fr
Priority to SU843754451A priority patent/SU1367859A3/ru
Priority to AR85300674A priority patent/AR242393A1/es
Priority to AR85300673A priority patent/AR242394A1/es
Priority to US06/858,573 priority patent/US4746654A/en
Application granted granted Critical
Publication of FR2531088B1 publication Critical patent/FR2531088B1/fr
Priority to US07/165,080 priority patent/US4876248A/en
Priority to SG185/88A priority patent/SG18588G/en
Priority to CS914191A priority patent/CZ419191A3/cs
Priority to HR921258A priority patent/HRP921258B1/xx
Priority to LV930143A priority patent/LV5524A3/xx
Priority to NL960007C priority patent/NL960007I2/nl
Priority to NO1998011C priority patent/NO1998011I1/no
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3865—Polyphosphonic acids containing sulfur substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/4043—Esters of poly(thio)phosphonic acids containing sulfur substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8213250A 1982-07-29 1982-07-29 Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation Expired FR2531088B1 (fr)

Priority Applications (42)

Application Number Priority Date Filing Date Title
FR8213250A FR2531088B1 (fr) 1982-07-29 1982-07-29 Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
IE1716/83A IE56343B1 (en) 1982-07-29 1983-07-21 Anti-inflammatory products derived from methylene-diphosphonic acid,and process for their preparation
DK336783A DK170342B1 (da) 1982-07-29 1983-07-22 Analogifremgangsmåde til fremstilling af methylendiphosphonsyrederivater
LU88723C LU88723I2 (fr) 1982-07-29 1983-07-25 Skelid
NO832701A NO164712C (no) 1982-07-29 1983-07-25 Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
AT83401520T ATE30235T1 (de) 1982-07-29 1983-07-25 Antiinflammatorische produkte von methylendiphosphonsaeure abgeleitet und verfahren zu ihrer herstellung.
EP83401520A EP0100718B1 (fr) 1982-07-29 1983-07-25 Produits anti-inflammatoires dérivés de l'acide méthylène-diphosphonique et leur procédé de préparation
DE8383401520T DE3374062D1 (en) 1982-07-29 1983-07-25 Anti-inflammatory products derived from methylenediphosphonic acid, and process for their preparation
IL69347A IL69347A (en) 1982-07-29 1983-07-26 Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
CA000433224A CA1267650A (en) 1982-07-29 1983-07-26 Derivatives of methylene diphosphonic acid, preparation of the same pharmaceutical compositions containing the same
PH29310A PH22082A (en) 1982-07-29 1983-07-27 Anti-inflammatory products derived from methylene-diphosphonic acid
AU17324/83A AU566880B2 (en) 1982-07-29 1983-07-27 Sulphur containing methylene diphosphonates
GR72051A GR79597B (enExample) 1982-07-29 1983-07-27
ES524495A ES524495A0 (es) 1982-07-29 1983-07-28 Procedimiento para la preparacion de derivados del acido metilendifosfonico
HU832658A HU190454B (en) 1982-07-29 1983-07-28 Process for preparing methylene-diphosphonic acid derivatives
NZ205061A NZ205061A (en) 1982-07-29 1983-07-28 Derivatives of methylene-diphosphonic acid and anti-inflammatory pharmaceutical compositions
OA58074A OA07507A (fr) 1982-07-29 1983-07-28 Produits anti-inflammatoires dérivés de l'acide méthylènediphosphodinique et leur procédé de préparation.
MA20079A MA19858A1 (fr) 1982-07-29 1983-07-28 Procede de preparation de derives de l'acide methylene disphosphonique .
KR1019830003523A KR910000726B1 (ko) 1982-07-29 1983-07-28 메틸렌-디포스폰산 유도체의 제조방법
PT77122A PT77122B (fr) 1982-07-29 1983-07-28 Procede de preparation de derives de l'acide methylenediphosphonique
PL1983259142A PL142022B1 (en) 1982-07-29 1983-07-29 Method of obtaining novel derivatives of methylenediphosphonic acid
SU833628775A SU1333240A3 (ru) 1982-07-29 1983-07-29 Способ получени производных метилендифосфоновой кислоты
FI832758A FI75830C (fi) 1982-07-29 1983-07-29 Foerfarande foer framstaellning av terapeutiskt anvaendbara metylendifosfonsyraderivat.
CS835688A CS252463B2 (en) 1982-07-29 1983-07-29 Method of methylenediphosphonic acid's derivatives production
PL1983243229A PL141316B1 (en) 1982-07-29 1983-07-29 Method of obtaining novel derivatives of methyldiphosphonic acids
YU1600/83A YU45143B (en) 1982-07-29 1983-07-29 Methylen-diphosphonic acid derivatives
DD83253536A DD213670A5 (de) 1982-07-29 1983-07-29 Verfahren zur herstellung von methylendiphosphonsaeurederivaten
JP58139324A JPS5942395A (ja) 1982-07-29 1983-07-29 メチレン−ジホスホン酸から誘導された炎症抑制性生成物およびその製造方法
ZA835578A ZA835578B (en) 1982-07-29 1983-07-29 Anti-inflammatory products derived from methylene-diphosphonic acid,and process for their preparation
EG468/83A EG15968A (en) 1982-07-29 1983-07-30 Process for the preparation of derivatives of methylene diphosphonic acid
DZ836911A DZ562A1 (fr) 1982-07-29 1983-11-27 Produits anti-inflammatoires dérivés de l'acide méthylènedihosphonique et leur procédé de préparation.
SU843754451A SU1367859A3 (ru) 1982-07-29 1984-06-26 Способ получени производных метилендифосфоновой кислоты
AR85300674A AR242393A1 (es) 1982-07-29 1985-06-11 Procedimiento de preparacion de derivados de acido metilendifosfonico.
AR85300673A AR242394A1 (es) 1982-07-29 1985-06-11 Procedimiento de preparacion de derivados de acido metilendifosfonico.
US06/858,573 US4746654A (en) 1982-07-29 1986-04-24 Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
US07/165,080 US4876248A (en) 1982-07-29 1988-03-07 Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
SG185/88A SG18588G (en) 1982-07-29 1988-03-23 Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
CS914191A CZ419191A3 (en) 1982-07-29 1991-12-31 Derivatives of methylenediphosphonic acid and medicaments in which said derivatives are comprised
HR921258A HRP921258B1 (en) 1982-07-29 1992-11-13 Methylenediphosphonic acid derivatives edmonds-alt, x
LV930143A LV5524A3 (lv) 1982-07-29 1993-02-25 Panemiens metilendifosfonskabes atvasinajumu iegusanai
NL960007C NL960007I2 (nl) 1982-07-29 1996-04-24 Antiflogistische produkten, die afgeleid zijn van methyleen.
NO1998011C NO1998011I1 (no) 1982-07-29 1998-03-06 Tiludronsyre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8213250A FR2531088B1 (fr) 1982-07-29 1982-07-29 Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation

Publications (2)

Publication Number Publication Date
FR2531088A1 FR2531088A1 (fr) 1984-02-03
FR2531088B1 true FR2531088B1 (fr) 1987-08-28

Family

ID=9276447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8213250A Expired FR2531088B1 (fr) 1982-07-29 1982-07-29 Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation

Country Status (35)

Country Link
US (2) US4746654A (enExample)
EP (1) EP0100718B1 (enExample)
JP (1) JPS5942395A (enExample)
KR (1) KR910000726B1 (enExample)
AR (2) AR242393A1 (enExample)
AT (1) ATE30235T1 (enExample)
AU (1) AU566880B2 (enExample)
CA (1) CA1267650A (enExample)
CS (1) CS252463B2 (enExample)
CZ (1) CZ419191A3 (enExample)
DD (1) DD213670A5 (enExample)
DE (1) DE3374062D1 (enExample)
DK (1) DK170342B1 (enExample)
DZ (1) DZ562A1 (enExample)
EG (1) EG15968A (enExample)
ES (1) ES524495A0 (enExample)
FI (1) FI75830C (enExample)
FR (1) FR2531088B1 (enExample)
GR (1) GR79597B (enExample)
HU (1) HU190454B (enExample)
IE (1) IE56343B1 (enExample)
IL (1) IL69347A (enExample)
LU (1) LU88723I2 (enExample)
MA (1) MA19858A1 (enExample)
NL (1) NL960007I2 (enExample)
NO (2) NO164712C (enExample)
NZ (1) NZ205061A (enExample)
OA (1) OA07507A (enExample)
PH (1) PH22082A (enExample)
PL (2) PL141316B1 (enExample)
PT (1) PT77122B (enExample)
SG (1) SG18588G (enExample)
SU (2) SU1333240A3 (enExample)
YU (1) YU45143B (enExample)
ZA (1) ZA835578B (enExample)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558837B1 (fr) * 1984-01-26 1986-06-27 Sanofi Sa Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
US5641762A (en) * 1985-05-02 1997-06-24 Research Corporation Technologies, Inc. Bone targeted inhibitors of carbonic anhydrase
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates
ES2039237T3 (es) * 1986-04-24 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para preparar nuevos compuestos de acido difosfonico.
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
KR880011136A (ko) * 1987-03-11 1988-10-26 모리오까 시게오 아졸- 아미노메틸렌 비스포스폰산 유도체
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
CH675422A5 (enExample) * 1988-03-31 1990-09-28 Symphar Sa
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ATE136870T1 (de) * 1988-11-01 1996-05-15 Arch Dev Corp Verfahren zur abtrennung von metallischen ionen mit phosphonsäuren als complexbildner
US5154843A (en) * 1989-02-08 1992-10-13 The Lubrizol Corporation Hydroxyalkane phosphonic acids and derivatives thereof and lubricants containing the same
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5220021A (en) * 1989-04-03 1993-06-15 The Upjohn Company Geminal bisphosphonic acids and derivatives as anti-arthritic agents
JPH0377894A (ja) * 1989-08-18 1991-04-03 Toray Ind Inc メチレンジホスホン酸化合物
DE69023844T2 (de) * 1989-09-06 1996-06-20 Merck & Co Inc Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
DE59107135D1 (de) * 1990-01-18 1996-02-08 Ciba Geigy Ag Phoshponsäure- und Thionophosphonsäure-Derivate
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
EP0544812B1 (en) * 1990-08-21 1995-04-05 The Upjohn Company Bisphosphonic acid derivatives as anti-arthritic agents
DK0561948T3 (da) * 1990-12-07 1995-08-21 Upjohn Co Phosphonsyrederivater, der kan anvendes som antiinflammatoriske midler
IE914417A1 (en) * 1990-12-19 1992-07-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
AU657554B2 (en) * 1991-06-19 1995-03-16 Pharmacia & Upjohn Company Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents
EP0521622B1 (en) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
JPH0826048B2 (ja) * 1991-09-05 1996-03-13 東レ株式会社 メタンジホスホン酸誘導体、その製造方法およびその医薬用途
JPH06172372A (ja) * 1991-11-06 1994-06-21 Takeda Chem Ind Ltd スクアレン合成酵素阻害剤およびその用途
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
JPH07506569A (ja) * 1992-05-29 1995-07-20 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド 異常カルシウム及びリン酸代謝と歯石及び歯垢を治療するための四級窒素含有ホスホネート化合物
NZ253524A (en) * 1992-05-29 1997-01-29 Procter & Gamble Pharma Sulphur-containing phosphonate derivatives and medicaments (for treating abnormal calcium and phosphate metabolism)
HUT69731A (en) * 1992-05-29 1995-09-28 Procter & Gamble Pharma Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
JPH07508279A (ja) * 1992-06-30 1995-09-14 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド ホスホネート類及びｎｓａｉｄを含有した関節炎の治療用組成物
DE69330114T2 (de) * 1992-07-10 2001-08-02 Toray Industries, Inc. Methandiphosphonat-derivat, dessen produktion und dessen verwendung als arzneimittel
GB9215433D0 (en) * 1992-07-21 1992-09-02 Cmb Foodcan Plc Apparatus for stripping a drawn article from a punch
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
JPH07509712A (ja) * 1992-08-07 1995-10-26 ジ・アップジョン・カンパニー 抗炎症剤としてのホスホノ酢酸エステルおよびホスホノ酢酸
EP0663919A1 (en) * 1992-10-09 1995-07-26 PHARMACIA & UPJOHN COMPANY Pyrimidine bisphosphonate esters as anti-inflamatories
JPH06135976A (ja) * 1992-10-30 1994-05-17 Toray Ind Inc メタンジホスホン酸誘導体、その製造方法およびその医薬用途
US5332728A (en) * 1992-11-23 1994-07-26 Bristol-Myers Squibb Company Method for treating a fungal infection
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
US6399592B1 (en) 1992-12-23 2002-06-04 Merck & Co., Inc. Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss
KR950701338A (ko) * 1993-02-25 1995-03-23 마에다 가쓰노스케 메탄디포스폰산 화합물의 제조방법(Process for producing methanediphosphonate compound)
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
DE69530064T2 (de) * 1994-08-24 2003-12-18 Toray Industries, Inc. Verfahren zur herstellung einer methanphosphonsäureverbindung
AU5973496A (en) 1995-06-06 1996-12-24 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
ES2239774T3 (es) * 1995-09-29 2005-10-01 Novartis Ag Metodo de tratamiento de la enfermedad navicular en caballos.
AU721320B2 (en) * 1996-10-09 2000-06-29 Elizanor Biopharmaceuticals, Inc. Diphosphonate therapeutic compounds
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
CA2343027A1 (en) 1998-09-09 2000-03-16 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
CN1217666C (zh) * 1998-12-25 2005-09-07 东丽株式会社 白介素－6产生抑制剂
AU6362100A (en) 1999-07-23 2001-02-13 Children's Hospital Of Philadelphia, The Derivatized polyurethane compositions and methods of making
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US6420384B2 (en) 1999-12-17 2002-07-16 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
CA2396713A1 (en) * 1999-12-22 2001-07-05 Metabasis Therapeutics, Inc. Novel bisamidate phosphonate prodrugs
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US7563774B2 (en) * 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP2260852A3 (en) * 2001-04-10 2011-01-12 MBC Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
US6558702B2 (en) * 2001-04-13 2003-05-06 Alkermes Controlled Therapeutics, Inc. Method of modifying the release profile of sustained release compositions
US20060269602A1 (en) * 2001-04-13 2006-11-30 Dasch James R Method of modifying the release profile of sustained release compositions
TWI315982B (en) * 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
MXPA04006027A (es) * 2001-12-21 2004-09-27 Procter & Gamble Metodo para el tratamiento de trastornos de los huesos.
AU2002364051A1 (en) * 2002-01-24 2003-09-02 Children's Medical Center Corporation Anti-cancer combination and use thereof
CA2480814A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
SI1506041T1 (sl) 2002-05-10 2008-02-29 Hoffmann La Roche Ibandronska kislina za zdravljenje in preprecevanje osteoporoze
WO2003103664A1 (en) * 2002-06-06 2003-12-18 Merck Frosst Canada & Co. 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
AU2003276990A1 (en) * 2002-09-26 2004-04-19 The Children's Hospital Of Philadelphia Derivatized polyurethane compositions which exhibit enhanced stability in biological systems and methods of making the same
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
WO2004056373A1 (en) 2002-12-20 2004-07-08 F. Hoffmann-La Roche Ag High dose ibandronate formulation
US7408014B2 (en) * 2003-07-08 2008-08-05 The Children's Hospital Of Philadelphia Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof
US7312353B2 (en) 2003-08-21 2007-12-25 Merck Frost Canada & Co. Cathespin cysteine protease inhibitors
BRPI0414565A (pt) * 2003-09-19 2006-11-07 Pfizer Prod Inc composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
WO2005115331A2 (en) 2004-05-24 2005-12-08 The Procter & Gamble Company Enteric solid oral dosage form of bisphosphonate containing a chelating agent
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2005277479A1 (en) * 2004-08-18 2006-03-02 Metabasis Therapeutics, Inc. Novel thiazole inhibitors of fructose 1,6-bisphosphatase
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
AU2006302797B2 (en) 2005-03-02 2012-02-02 Merck Canada Inc. Composition for inhibition of cathepsin K
MX2007011495A (es) * 2005-03-17 2007-12-06 Elan Pharma Int Ltd Composiciones de bifosfonato en nanoparticulas.
AU2006226818B2 (en) * 2005-03-24 2011-05-12 Medtronic, Inc. Modification of thermoplastic polymers
DK2222636T3 (da) 2007-12-21 2013-06-03 Ligand Pharm Inc Selektive androgenreceptormodulatorer (SARMS) og anvendelser deraf
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
WO2010143193A1 (en) 2009-06-11 2010-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
US8791162B2 (en) 2011-02-14 2014-07-29 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
SMT202000485T1 (it) 2011-07-13 2020-11-10 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Liposomi co-incapsulanti un bisfosfonato e un agente anfipatico
EP2739154B1 (en) 2011-08-01 2018-06-27 MBC Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
WO2015051479A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
JP6454335B2 (ja) 2013-10-08 2019-01-16 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． カテプシンシステインプロテアーゼ阻害剤
WO2015120580A1 (en) 2014-02-11 2015-08-20 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
PL407922A1 (pl) 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie
US10328082B2 (en) 2014-05-30 2019-06-25 Pfizer Inc. Methods of use and combinations
EP3956309A4 (en) 2019-04-19 2023-06-07 Ligand Pharmaceuticals Inc. CRYSTALLINE FORMS AND METHODS FOR PRODUCING CRYSTALLINE FORMS OF A COMPOUND
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302557B (enExample) * 1963-04-09 1971-08-26
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3705191A (en) * 1970-04-13 1972-12-05 Monsanto Co Substituted ethane diphosphonic acids and salts and esters thereof
US3654151A (en) * 1970-04-13 1972-04-04 Monsanto Co Deflocculation of solid materials in aqueous medium
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4171373A (en) * 1974-01-07 1979-10-16 William H. Rorer, Inc. Ethynylbenzene compounds and derivatives thereof to treat pain, fever and inflammation
US4071584A (en) * 1977-01-03 1978-01-31 Monsanto Company Hydroxyphenylthiophosphoranylidene organophosphorus compounds
US4264582A (en) * 1978-07-31 1981-04-28 The Procter & Gamble Company Isobutylphenylacetate anti-inflammatory composition
JPS5598193A (en) * 1979-01-22 1980-07-25 Nissan Chem Ind Ltd Methylenediphosphonic acid derivative and herbicide comprising it as active constituent
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
EP0085321B1 (de) * 1982-01-27 1986-08-27 Schering Aktiengesellschaft Diphosphonsäure-Derivate und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
PT77122A (fr) 1983-08-01
MA19858A1 (fr) 1984-04-01
IE831716L (en) 1984-01-29
NO1998011I1 (no) 1998-03-06
YU160083A (en) 1986-08-31
AU1732483A (en) 1984-02-02
NL960007I1 (nl) 1996-09-02
DE3374062D1 (en) 1987-11-19
EG15968A (en) 1989-01-30
NO832701L (no) 1984-01-30
FI75830C (fi) 1988-08-08
JPH0429676B2 (enExample) 1992-05-19
CS252463B2 (en) 1987-09-17
EP0100718B1 (fr) 1987-10-14
US4746654A (en) 1988-05-24
CA1267650A (en) 1990-04-10
FI832758A0 (fi) 1983-07-29
ES8403923A1 (es) 1984-04-16
LU88723I2 (fr) 1996-08-23
PL243229A1 (en) 1984-07-16
IE56343B1 (en) 1991-07-03
NL960007I2 (nl) 1997-03-03
AU566880B2 (en) 1987-11-05
FR2531088A1 (fr) 1984-02-03
IL69347A0 (en) 1983-11-30
HU190454B (en) 1986-09-29
KR910000726B1 (ko) 1991-01-31
SU1367859A3 (ru) 1988-01-15
EP0100718A1 (fr) 1984-02-15
PL142022B1 (en) 1987-09-30
YU45143B (en) 1992-03-10
NO164712C (no) 1990-11-07
ES524495A0 (es) 1984-04-16
FI832758L (fi) 1984-01-30
DK336783A (da) 1984-01-30
GR79597B (enExample) 1984-10-31
ATE30235T1 (de) 1987-10-15
PH22082A (en) 1988-05-20
AR242394A1 (es) 1993-03-31
NZ205061A (en) 1987-08-31
DK170342B1 (da) 1995-08-07
PT77122B (fr) 1986-01-24
SU1333240A3 (ru) 1987-08-23
PL141316B1 (en) 1987-07-31
DD213670A5 (de) 1984-09-19
CS568883A2 (en) 1987-01-15
NO164712B (no) 1990-07-30
IL69347A (en) 1987-02-27
ZA835578B (en) 1984-04-25
AR242393A1 (es) 1993-03-31
KR840005459A (ko) 1984-11-12
DK336783D0 (da) 1983-07-22
OA07507A (fr) 1985-03-31
US4876248A (en) 1989-10-24
SG18588G (en) 1988-09-30
FI75830B (fi) 1988-04-29
JPS5942395A (ja) 1984-03-08
CZ419191A3 (en) 1993-10-13
DZ562A1 (fr) 2004-09-13

Similar Documents

Publication Publication Date Title
FR2531088B1 (fr) Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
FR2483409B1 (fr) Derives de l'acide 3-amino-2-hydroxy butanoylaminoacetique et leur procede de preparation
BE887574R (fr) Derives de l'acide quinoleine-carboxylique et procede pour leur preparation
MA18731A1 (fr) B-lactames derives de l'acide penicillamique et leur preparation
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
FR2554809B1 (fr) Procede de preparation de l'acide acrylique
PT76763B (fr) Procede de preparation de compositions a base de fluorochlorohydrocarbure d'ester phosphorique et d'acide carboxilique
FR2496106B1 (fr) Derives d'acide 7-acylaminocephalosporanique et procede pour leur preparation
FR2510583B1 (fr) Derives nouveaux d'acide ursodesoxycholique, leur procede de preparation et leur application en therapeutique
BE875882A (fr) Composes derives de l'acide cyclohexylcarboxylique et leur procede de preparation
FR2612373B1 (fr) Compositions dietetiques et procede pour leur preparation
FR2558832B1 (fr) Derives de l'acide carbamique et leur procede d'obtention
FR2506313B1 (fr) Derives de l'acide n-acetylneuraminique et leur preparation
FR2559766B1 (fr) Procede de preparation de derives de l'acide carbamique
BE891790A (fr) Nouveaux derives d'acide guanidinocyclohexane-carboxylique et leur procede de production
RO88451A2 (ro) Derivati ai acidului 7-aminocefalosporanic si procedeu de preparare aacestora
FR2537137B1 (fr) Procede de preparation de derives de l'acide 2-thiophene acetique et produits intermediaires necessaires pour leur preparation
FR2552090B1 (fr) Procede de preparation de produits intermediaires de la preparation d'acides phosphiniques
FR2546889B1 (fr) Procede de preparation d'un acide aminolactonecarboxylique
BE889169A (fr) Procede de preparation d'acide 2-methoxy-3-6-dichloro-benzoique
FR2542758B1 (fr) Procede de preparation de l'acide l-glutamique
FR2600059B1 (fr) Derives de l'acide benzoique et leur procede de preparation
BE894154A (fr) Procede de preparation d'esters des acides alkoxyvincaminiques et alkoxyapovincaminiques
FR2590894B1 (fr) Derives d'acide amino-4 butanoique, leur procede de preparation et leur utilisation
FR2518539B1 (fr) Procede de preparation d'esters de l'acide nitroacetique

Legal Events

Date Code Title Description
ST Notification of lapse